OpenAI's Rosalind Academic Plan Opens Free AI Research Access for US Labs

OpenAI launched a program giving US university research labs up to 30 free AI seats for life sciences work, with strict vetting and safety protocols.

OpenAI has launched the Rosalind Academic Plan for research labs at US universities, providing up to 30 free seats on its Business Standard plan for up to 12 months. The program exclusively uses GPT-Rosalind, an AI model engineered for life sciences applications, and integrates with tools for medicinal chemistry, genomics, and lab experiments. To access, labs must undergo vetting of the institution, lead researcher, and intended research use, with OpenAI applying context-specific safety checks for sensitive applications and never training on research data by default.

This approach lowers the cost barrier for academic AI research in critical health fields without requiring enterprise contracts. By enabling labs to use specialized AI tools for drug discovery and genomic analysis without upfront licensing fees, the plan accelerates knowledge creation in areas directly tied to medical care and health goods. The requirement for researcher vetting ensures responsible use while avoiding data leakage risks.

For the need of health, this could speed up targeted medical research without enterprise contracts. However, the program remains restricted to US universities and does not include API access, meaning labs must apply through OpenAI’s help center. The next phase will depend on whether the model’s real-world impact in life sciences meets the vetting standards and whether non-US institutions can later access similar tools through expanded pathways.

Source: The Decoder